Saade A, Wyplosz B, Baldeyrou M, Paris C, Tattevin P, Janssen C. Infection prevention for immunocompromised patients: A cross-translational multicentric survey of current organization in France.
Infect Dis Now 2024;
54:104863. [PMID:
38340891 DOI:
10.1016/j.idnow.2024.104863]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2023] [Revised: 02/01/2024] [Accepted: 02/05/2024] [Indexed: 02/12/2024]
Abstract
OBJECTIVES
To evaluate current organization of infection prevention for immunocompromised patients (ICP) at a countrywide level.
METHODS
Nationwide cross-sectional multicenter study based on an online survey disseminated in 2022 to physicians invested with preventive healthcare missions.
RESULTS
A total of 341 physicians (96% graduates, 32% infectious disease specialists), participated in the survey, with a median age of 40 [35-51] years. On-site access to infection prevention consultations for ICP was reported by 30%, dedicated pre-travel consultations for ICPs by 29%, consultations for infection prevention in solid organ transplant candidates by 16% and return-to-work consultations for ICPs by 6%. Most participants (73%) were aware of nationwide vaccination guidelines for ICP, while 50% felt comfortable using them. Tools for infection prevention advice and ICP vaccination had been developed by 10%, while 89% would have appreciated access to tools developed by others.
CONCLUSIONS
Infection prevention for ICPs remains neglected. Guidelines covering all fields of prevention for ICPs would be more than welcome.
Collapse